The pharmaceutical industry stands at a critical crossroads, grappling with the staggering statistic that developing a single new drug can cost upwards of $2.6 billion and take over a decade from discovery to market, pushing the sector to seek groundbreaking solutions. Artificial Intelligence (AI)
In the fast-evolving landscape of biopharmaceutical production, ensuring the consistency of cell culture media stands as a cornerstone for achieving reliable cell growth and high-quality therapeutic products, especially given the complexity of these media formulations. With hundreds of components
Thyroid cancer, recognized as the most prevalent endocrine malignancy and ranking ninth among cancers globally, poses a significant health challenge with its diverse subtypes ranging from the more treatable papillary thyroid carcinoma to the highly aggressive anaplastic thyroid carcinoma, each
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned expert in biopharmaceuticals with a deep focus on technology and innovation in the industry. With extensive experience in research and development, Ivan has been at the forefront of advancing cancer treatments, particularly in the
What happens when a chronic disease like systemic lupus erythematosus (SLE) steals not just health, but the very essence of daily life from millions worldwide, leaving them to grapple with relentless pain, fatigue, and organ damage? For over 3.4 million people battling this autoimmune condition, a
The biopharmaceutical industry is undergoing a profound transformation this year, as financial strategies adapt to a landscape shaped by economic pressures and groundbreaking innovation. With venture capital tightening its grip on risk, mergers and acquisitions gaining momentum, and licensing deals
